Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, February 28, 2020
[ Fri, Feb 28th 2020
] - WOPRAI
[ Fri, Feb 28th 2020
] - WOPRAI
[ Fri, Feb 28th 2020
] - WOPRAI
[ Fri, Feb 28th 2020
] - WOPRAI
[ Fri, Feb 28th 2020
] - WOPRAI
[ Fri, Feb 28th 2020
] - WOPRAI
[ Fri, Feb 28th 2020
] - WOPRAI
[ Fri, Feb 28th 2020
] - WOPRAI
[ Fri, Feb 28th 2020
] - WOPRAI
[ Fri, Feb 28th 2020
] - WOPRAI
[ Fri, Feb 28th 2020
] - WOPRAI
[ Fri, Feb 28th 2020
] - WOPRAI
[ Fri, Feb 28th 2020
] - WOPRAI
[ Fri, Feb 28th 2020
] - WOPRAI
[ Fri, Feb 28th 2020
] - WOPRAI
[ Fri, Feb 28th 2020
] - WOPRAI
[ Fri, Feb 28th 2020
] - WOPRAI
[ Fri, Feb 28th 2020
] - WOPRAI
Thu, February 27, 2020
[ Thu, Feb 27th 2020
] - WOPRAI
[ Thu, Feb 27th 2020
] - WOPRAI
[ Thu, Feb 27th 2020
] - WOPRAI
[ Thu, Feb 27th 2020
] - WOPRAI
[ Thu, Feb 27th 2020
] - WOPRAI
[ Thu, Feb 27th 2020
] - WOPRAI
[ Thu, Feb 27th 2020
] - WOPRAI
[ Thu, Feb 27th 2020
] - WOPRAI
[ Thu, Feb 27th 2020
] - WOPRAI
[ Thu, Feb 27th 2020
] - WOPRAI
Charles Duncan Reiterated (ACAD) at Buy with Increased Target to $75 on, Feb 27th, 2020
Charles Duncan of Cantor Fitzgerald, Reiterated "ACADIA Pharmaceuticals Inc." (ACAD) at Buy with Increased Target from $70 to $75 on, Feb 27th, 2020.
Charles has made no other calls on ACAD in the last 4 months.
There is 1 other peer that has a rating on ACAD. Out of the 1 peers that are also analyzing ACAD, 0 agree with Charles's Rating of Hold.
This is the rating of the analyst that currently disagrees with Charles
- Yatin Suneja of "Guggenheim" Initiated at Strong Buy and Held Target at $60 on, Monday, December 16th, 2019
Similar Stocks and Investing Articles
[ Tue, Feb 11th 2020
] - WOPRAI
[ Fri, Feb 07th 2020
] - WOPRAI
[ Mon, Dec 30th 2019
] - WOPRAI
[ Mon, Dec 16th 2019
] - WOPRAI
[ Tue, Nov 26th 2019
] - WOPRAI
[ Thu, Oct 24th 2019
] - WOPRAI
[ Tue, Oct 01st 2019
] - WOPRAI
[ Tue, Aug 27th 2019
] - WOPRAI
[ Wed, Feb 28th 2018
] - WOPRAI
[ Fri, Jan 27th 2017
] - WOPRAI